IL-1 BETA FOR THE PRO-INFLAMMATORY STIMULATION OF A CUTANEOUS SUBSTITUTE OR EXPLANT
The present invention relates to the use of a pro-inflammatory stimulating reagent containing between 10 and 500 ng/mL of interleukin IL-1β to reproduce the physiopathology of atopic dermatitis in vitro and/or to alter the barrier function in a cutaneous substitute or a cutaneous explant. It also re...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
14.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!